Loss of Tumour Suppressor TMEM127 Drives RET-mediated Transformation Through Disrupted Membrane Dynamics

Timothy J Walker1, Eduardo Reyes-Alvarez1, Brandy D Hyndman1

  • 1Division of Cancer Biology and Genetics, Cancer Research Institute, and Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, K7L 3N6, Canada.

Insights

Loss of TMEM127 causes receptor tyrosine kinases (RTK) to accumulate on the cell surface, driving pheochromocytoma (PCC) development. This study reveals TMEM127

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Receptor tyrosine kinases (RTK) regulate cell signaling, and their dysregulation is common in cancer.
  • Pheochromocytoma (PCC) can arise from RET mutations or TMEM127 inactivation, a tumor suppressor involved in endosomal trafficking.
  • The precise role of aberrant receptor trafficking in PCC pathogenesis remains unclear.

Conclusions:

  • TMEM127 is crucial for maintaining membrane organization, protein complex assembly, and proper trafficking of transmembrane proteins.
  • Aberrant membrane dynamics and consequent cell surface accumulation of growth factor receptors, like RET, driven by TMEM127 loss, represent a novel mechanism for oncogenesis in PCC.
  • This provides a new paradigm for understanding pheochromocytoma development through altered membrane protein regulation and signaling.